Vitiligo is a skin condition characterized by the loss of skin color in patches. It affects people of all ages and skin types, and is caused by the destruction of melanocytes, the cells responsible for skin pigmentation. Treatment options for vitiligo include topical medications, phototherapy, and surgical procedures. The vitiligo market within the context of dermatology is a growing field, with a range of products and services available to treat the condition. Topical medications, such as corticosteroids and calcineurin inhibitors, are commonly used to reduce the appearance of vitiligo. Phototherapy, such as narrowband UVB, is also used to stimulate the production of melanocytes. Surgical procedures, such as skin grafting and tattooing, are also available to treat vitiligo. Companies in the vitiligo market include Galderma, Leo Pharma, and Sun Pharma. Other companies, such as Allergan, Mylan, and Teva, also offer products and services for the treatment of vitiligo. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
